Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (Diluted Average) (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $458.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.22% year-over-year to $458.0 million, compared with a TTM value of $458.0 million through Dec 2025, changed 0.22%, and an annual FY2025 reading of $458.0 million, changed 0.22% over the prior year.
  • Shares Outstanding (Diluted Average) was $458.0 million for Q4 2025 at GE HealthCare Technologies, roughly flat from $458.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $459.0 million in Q1 2024 and bottomed at $454.0 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $457.3 million, with a median of $458.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) increased 0.88% in 2023, then fell 0.22% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $454.0 million in 2022, then rose by 0.88% to $458.0 million in 2023, then grew by 0.22% to $459.0 million in 2024, then decreased by 0.22% to $458.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GEHC at $458.0 million in Q4 2025, $458.0 million in Q3 2025, and $459.0 million in Q2 2025.